Radiation Oncology Training Requirements - Phase 2

Phase 2 Training Requirements

Patient Encounter Assessment Tool (PEAT)

A minimum of 15 assessments. Five of these assessments must include the Clinical Supervisor observing the trainee with the patient.

Contouring and Plan Evaluation Tool (CPET)

A minimum of 15 assessments.                                                                                                           

Case Report and Discussion Tool (CRDT)

A minimum of 20 assessments. At least five assessments on lesser focus topics, two on in-patient care and five on specific techniques.

Communication Skills Tool (CST)

Assessments of the trainee’s communication skills in specific contexts including:

  • during an initial consultation
  • a follow up consultation or treatment review
  • explaining a management plan to a patient and obtaining informed consent 
  • breaking bad news

A minimum of one Work-Based Assessment should be completed each month to obtain regular feedback.

SMART Workshops

Trainees are required to complete at least one SMART workshop and are encouraged to do so within the first six months of Phase 2 to provide the foundation for their engagement in their research project.

Phase 2 Practical Oncology Experiences (POEs)

Two sessions with patients being managed by a specialist palliative care team

Two sessions with patients undergoing surgery

Two sessions with patients receiving systemic therapy

Four sessions focusing on any treatment modality

Clinical Supervisor Appraisal every three months.

Director of Training Review every six months.

Phase 2 Review of trainees’ portfolios at no later than 36 months into Phase 2, to check progress toward presenting for the Part 2 Examination.

One Multisource Feedback (MSF) to be completed for eligibility for the Phase 2 Examination.

Trainees must complete the Trainee Assessment of Training Sites (TATS) every six months.

Trainees must complete a minimum 24 months of accredited training time in Phase 2, all WBAs, an MSF and all Structured Learning Experiences to be eligible to apply for the Phase 2 Examination.

Phase 2 Examination – four written papers and viva voce examinations (vivas).

For eligibility of Fellowship:

  • Presenting at a multidisciplinary meeting
  • Recruiting a patient to a clinical trial
  • Running a meeting 

For eligibility of Fellowship, trainees are required to submit a manuscript of their research project to an acceptable journal. Trainees may select one of three options:

  1. Original Research Study
  2. Cochrane Protocol or Review
  3. Prospective Study

Trainees may present for portfolio review by Network Portfolio Review Committee, after completion of all training requirements.

Overall, the trainee’s ePortfolio must:

  • record the completion of all training program requirements
  • demonstrate progress leading to competence across the breadth of the curriculum (a variety of clinical cases of differing complexity), as assessed by multiple assessors
  • demonstrate the achievement of competence across the intrinsic roles.

As a guide, Trainees must achieve Level 4 on the overall entrustability scale for at least half of the PEAT, CPET and CRDT, and on the CST for each scenario.